Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling

Biochemical and Biophysical Research Communications

Volumn 426, Issue 4, 2012, Pages 461-467

  Park, Jung Jin ^a,b   Seo, Seon Mi ^a,c   Kim, Eun Ju ^a   Lee, Yoon Jin ^a   Ko, Young Gyu ^b   Ha, Joohun ^c   Lee, Minyoung ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

AMP activated protein kinase; Berberine; Colon cancer; Integrin 1

Indexed keywords

ADENOSINE PHOSPHATE; BERBERINE; BETA1 INTEGRIN;

ARTICLE; CANCER CELL; CANCER THERAPY; CELL MIGRATION; CELL STRAIN HCT116; COLON CANCER; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE;

AMP-ACTIVATED PROTEIN KINASES; ANTIGENS, CD29; ANTINEOPLASTIC AGENTS; BERBERINE; CELL MOVEMENT; COLONIC NEOPLASMS; DOWN-REGULATION; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84867193563     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.091     Document Type: Article

References (27)

1. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim. Biophys. Acta 2009, 1796:293-308.
2. Ismaili N. Treatment of colorectal liver metastases. World J. Surg. Oncol. 2011, 9:154.
3. Grundmann R.T. Current state of surgical treatment of liver metastases from colorectal cancer. World J. Gastrointest. Surg. 2011, 3:183-196.
4. Misiakos E.P., Karidis N.P., Kouraklis G. Current treatment for colorectal liver metastases. World J. Gastroenterol. 2011, 17:4067-4075.
5. Tillhon M., Guaman Ortiz L.M., Lombardi P., Scovassi A.I. Berberine: new perspectives for old remedies. Biochem. Pharmacol. 2012.
6. Vuddanda P.R., Chakraborty S., Singh S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig. Drugs 2010, 19:1297-1307.
7. Hardie D.G. Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr. 2011, 93:891S-896.
8. Hardie D.G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011, 25:1895-1908.
9. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13:251-262.
10. Marcus A.I., Zhou W. LKB1 regulated pathways in lung cancer invasion and metastasis. J. Thorac. Oncol. 2010, 5:1883-1886.
11. Saxena N.K., Sharma D. Metastasis suppression by adiponectin: LKB1 rises up to the challenge. Cell Adh. Migr. 2010, 4:358-362.
12. Shaw R.J. Tumor suppression by LKB1: SIK-ness prevents metastasis. Sci. Signal. 2009, 2:55.
13. Barkan D., Chambers A.F. Beta1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin. Cancer Res. 2011, 17:7219-7223.
14. Hehlgans S., Haase M., Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 2007, 1775:163-180.
15. Lee M., Lee H.J., Seo W.D., Park K.H., Lee Y.S. Sialylation of integrin beta1 is involved in radiation-induced adhesion and migration in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:1528-1536.
16. Playford M.P., Schaller M.D. The interplay between Src and integrins in normal and tumor biology. Oncogene 2004, 23:7928-7946.
17. Merrill G.F., Kurth E.J., Hardie D.G., Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273:E1107-1112.
18. Woods A., Azzout-Marniche D., Foretz M., Stein S.C., Lemarchand P., Ferre P., Foufelle F., Carling D. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell Biol. 2000, 20:6704-6711.
19. Lee M., Hwang J.T., Lee H.J., Jung S.N., Kang I., Chi S.G., Kim S.S., Ha J. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem. 2003, 278:39653-39661.
20. Kim H.S., Hwang J.T., Yun H., Chi S.G., Lee S.J., Kang I., Yoon K.S., Choe W.J., Kim S.S., Ha J. Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53. J. Biol. Chem. 2008, 283:3731-3742.
21. Gupta S.C., Kim J.H., Prasad S., Aggarwal B.B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010, 29:405-434.
22. Cordes N., Park C.C. Beta1 integrin as a molecular therapeutic target. Int. J. Radiat. Biol. 2007, 83:753-760.
23. Wellen K.E., Thompson C.B. A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell. Biol. 2012, 13:270-276.
24. Tseng C.H. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan. Eur. J. Endocrinol. 2012.
25. Din F.V., Valanciute A., Houde V.P., Zibrova D., Green K.A., Sakamoto K., Alessi D.R., Dunlop M.G. Aspirin inhibits mTOR signaling activates AMP-activated protein kinase and induces autophagy in colorectal cancer cells. Gastroenterology 2012, 142:1504-1515. e1503.
26. Hawley S.A., Fullerton M.D., Ross F.A., Schertzer J.D., Chevtzoff C., Walker K.J., Peggie M.W., Zibrova D., Green K.A., Mustard K.J., Kemp B.E., Sakamoto K., Steinberg G.R., Hardie D.G. The ancient drug salicylate directly activates AMP-activated protein kinase. Science 2012, 336:918-922.
27. Janik M.E., Litynska A., Vereecken P. Cell migration-the role of integrin glycosylation. Biochim. Biophys. Acta 1800, 2010:545-555.